Abstract A natural polysaccharide was isolated from the seeds of Delonix regia. The isolated polysaccharide could maintain aqueous equilibrium between the dosage form and the surrounding medium due to its massive competence of water absorption (80.72%) and swelling index (266.7%). The Scanning Electron Micrograph of a polysaccharide exhibits rough surface with pores and crevices, hence, the drug release will be retarded because of the drug particles entrapment in the pores and crevices. Further, the surface tension of polysaccharide is higher than that of water, which may facilitate sustained release of drugs from dosage forms. An antipsychotic drug, quetiapine fumarate has a short half-life of 6 h and administered multiple times per day. Hence the quetiapine fumarate oral sustained release tablets were formulated using this polysaccharide in the concentration of 5-30% to avoid the side effects and increase patient compliance. Dissolution of the developed tablets with 25% polysaccharide content showed a better release profile than the other batches (5-20%) at the end of 12 h. The strong matrix complex has low solubility in water, it does not dissolve rapidly and the drug continues to diffuse through the gel layer at a consistent rate. Drug release from the matrix tablets follows matrix type except F-4 and F-5 which follow first order and Hix.crow type. The bioavailability study was carried out using healthy male New Zealand white rabbits that show the AUC (0-inf) value for developed SR tablets is 1.44 times higher than the reference thus, indicating more efficient and sustained drug delivery capable of maintaining plasma drug levels better.
Introduction
Sustained release (SR) technology has rapidly emerged over the past three decades as a new interdisciplinary science that offers novel approaches to the delivery of bioactive agents into systemic circulation at a predetermined rate. By developing a predictable and reproducible drug release rate for an extended period of time, SR formulations can achieve optimum therapeutic responses, prolonged efficacy and decreased toxicity.
Hydrophilic matrix tablets are among the most popular delivery systems for oral sustained release dosage forms through the gastrointestinal (GI) route. This is largely because they offer precise modulation of drug release as a result of hydration of the constituent polymer(s), flexibility to obtain the desired drug release profiles, cost effectiveness, patient compliance and providing a constant, prolonged, and uniform therapeutic effect in blood levels of the drug unlike conventional systems (Heng et al., 2001) .
The use of hydrophilic polymers for sustained drug delivery has attracted the attention of investigators in recent years. Among the hydrophilic polymers, natural polysaccharides are preferred due to their nontoxicity, biocompatibility, biodegradability and acceptance by the regulating agencies. Polysaccharides, like cellulose ethers, xanthan gum, scleroglucan, locust bean gum and guar gum, are some of the natural polysaccharides that have been evaluated in hydrophilic matrix tablets for drug delivery systems (Tommasina et al., 2007) .
Considerable research carried out on locust bean gum (Sujja et al., 1998) , guar gum (Krishnaiah et al., 2002) , and tamarind gum (Yamanaka et al., 2000) reveals that polysaccharides can be isolated from their seeds or whole fruits. Delonix regia belongs to the same type containing the pod type fruits. It is a flowering plant from the Fabaceae family, noted for its fern-like leaves and flamboyant display of flowers (Silvana et al., 2001) . It usually grows to a modest height (typically around 5 m, though it can reach as high as 12 m) but spreads widely, and its dense foliage provides full shade. Seed pods are dark brown and can be up to 60 cm long and 5 cm wide; the individual seeds, however, are small, weighing around 0.4 g on average. In India, it is referred to as Gulmohar. Sandra et al. (2003) have studied on the three-dimensional structure of a novel Kunitz (STI) family member an inhibitor purified from D. regia seeds. Generally, its pods and seeds are considered as wastage and that too there is no work that has been carried out related to polysaccharide for sustained release formulation.
The aim of the present investigation is, therefore, to isolate natural polysaccharide from the seeds of D. regia and evaluate it for sustaining release carrier, using quetiapine fumarate as a model drug. The isolated polysaccharide named is as Gulmohar gum (GG) by authors for further reference.
Quetiapine fumarate (QF), 2-[2-(4-dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy] ethanol fumarate, is an antipsychotic drug belonging to a chemical class of dibenzothiazepine derivatives (Ihor and Lisa, 1997; Andrew et al., 2002) . It is indicated for the treatment of acute manic episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium. It is also used for the treatment of schizophrenia. Dyspnea, swelling of the face, lips, tongue, or throat and sedation are the most common side effects and other side effects are mood or behavior changes, anxiety, panic attacks, aggressiveness, restlessness, hyperactivity, constipation, headache, dry mouth and mild weight gain or weight loss (Diletti et al., 1991) . QF is well absorbed and extensively metabolised following oral administration. It has a short half-life of 6 h and administered orally 2-4 times a day. The frequency of dose administration leads to increase in the risk of side effects and decrease in patient compliance. Though patient compliance is best with one dose daily, the risk of schizophrenia recurrence after missing a dose may also be furthermost. The sustained release QF may effective serum levels for 24 h, and therefore, missing a dose could result insufficient therapeutic cover for many hours. Other reason for developing a QF sustained release formulation is to allowing use of longer dosing intervals. In addition, this regimen may be related with subtle psychological assistances, particularly for those patients who are schizophrenia or manic-free and recognize each dose taking act as an obnoxious remainder of their disease. Thus the development of QF SR formulation is required.
Materials and methods
Gulmohar seeds were collected in Kumbakonam, Middle Eastern part of Tamilnadu, India. Quetiapine fumarate (QF) was procured from Beijing Lunarsun Pharmaceutical Co., Ltd., China. PVP-K-30 (Poly vinyl pyrolidine from ISP) was a gift sample from Anshul agencies, Mumbai. Starch 1500 was a gift sample from Colorcon, India. Aerosil (colloidal silicon dioxide) was purchased from Degussa, Mumbai. All the reagents and chemicals used for analytical development were of HPLC grade.
Isolation of the polysaccharide GG
Gulmohar seeds (100 g) were soaked in 800 ml of warm water for 24 h. The water was discarded and the seeds were immersed in 800 ml of fresh boiling water for 4-5 h. The seeds were then removed from water, washed and the tegument broken and separated manually from the seed coat. The thick transparent cotyledon portion was separated from the seed coat and the embryonic axis. The cotyledon portions were milled and squeezed using several folds of muslin cloth to separate the marc from the filtrate. Absolute alcohol was then added to the filtrate to precipitate the polysaccharide. The polysaccharide was separated by filtration and dried in an oven at 60°C until constant weight. The dried polysaccharide film was milled and sifted with an 80 mesh sieve to obtain the flour (GG). The crude polysaccharide was purified through barium complexing by preparing 2.5% (w/v) solution of the gum by continuous stirring for 12 h at 60°C and precipitating with saturated barium hydroxide solution. The complex was separated by centrifugation and taken in 1 M acetic acid, stirred for 8 h, centrifuged and precipitated with absolute alcohol. It was washed with absolute alcohol for 4-5 times. The sample was finally purified by dialysis and filtration through various Millipore membranes (0.65 lm and 0.45 lm).
Evaluation of the polysaccharide
Phytochemical screening was carried out to check the polysaccharide purity (Evans et al., 1996) . The physicochemical properties were analyzed according to the Indian Pharmacopoeia (1996) . The pH of 1% aqueous solution was determined using a digital pH meter. Color and clarity were determined by dissolving 100 mg of the polysaccharide in carbon dioxide free water and checking for its clarity against a dark background. Surface tension was determined by the drop count method using a stalagmometer. Carr's index, water absorption study and swelling index (Alka et al., 1995) have also been carried out.
2.3. Toxicity studies 2.3.1. Acute oral toxicity study of the polysaccharide The polysaccharide was tested for acute oral toxicity in female Wistar rats as per the OECD guideline for the testing of chemicals, ''Acute Oral Toxicity Study (UP and DOWN Method)'', Guideline No. 425. The test was carried out by using five female rats (one animal per step) with a starting dose of 175 mg/kg and it was tested up to 2000 mg/kg b.wt. dose. The test item was prepared as a solution in water and administered as a single oral dose to overnight fasted (16-18 h) rats at the dose volume of 10 ml/kg b.wt. Mortality, clinical observations, body weights and gross necropsy findings were evaluated.
2.3.2. Repeated dose (28 day) oral toxicity study of the polysaccharide The polysaccharide was tested for its toxic effects in a 28 day oral toxicity study in Wistar rats. The test item was prepared as a solution in water and administered by oral gavage at doses of 10, 50, and 100, mg/kg b.wt. to G2, G3 and G4 groups of rats, respectively. The concurrent control group (G1) received water without the test item. All the groups consisted of 5 male and 5 female rats. Animals from all the groups were observed for clinical signs, physical abnormalities, changes in body weight and pre-terminal deaths. Laboratory investigations such as hematology and clinical chemistry were performed at sacrifice and the data were statistically analyzed. The rats were subjected to detailed necropsy at terminal sacrifice.
Compatibility study
The drug, the polysaccharide and the optimized formulation were subjected to Differential Scanning Calorimetry (DSC) using a Perkin Elmer SERIES DSC7, United Kingdom. Accurately weighed samples (3-7 mg) were hermetically sealed in flat bottomed aluminum pans and heated from 50 to 360°C at a rate of 20°C per min in an atmosphere of nitrogen. The thermograms were normalized. FTIR studies were also performed on the drug, the polysaccharide and the optimized formulation using FTIR Shimadzu., Japan.
Development of SR tablets, evaluation and in vitro drug release studies
Six batches of QF SR tablets were prepared according to the composition shown in Table 1 corresponding to different GG concentrations of 5%, 10%, 15%, 20%, 25%, and 30% , coded as, F-1, 2, 3, 4, 5 and 6 respectively. Drug with and without the diluents was deagglomerated using the British Standard Sieve (BSS) with 0.25 mm opening. The premix and the polysaccharide were granulated using PVP-K-30 in isopropyl alcohol as the granulating fluid. The wet mass was passed manually through BSS with 1.7 mm opening. The granulations were dried at 60°C for 2 h until the loss on drying of the granules was between 1% and 2% w/w. The dried granules were passed through BSS 1.0 mm and evaluated for flow properties and compressibility index (Banker and Anderson, 1987) . The granules were blended with magnesium stearate and aerosil. The blends were compressed using 12 mm flat punches on a rotary tablet press. The thickness of the tablets was determined using a thickness gauge (Mitutoyo, New Delhi, India). Weight variation was recorded using an electronic balance (Sartorius India limited, India). The hardness and friability were determined using the Monsanto hardness tester (Cadmach, Ahmedabad, India) and the Roche friabilator (Electrolab, Mumbai, India), respectively. Drug content of the tablets was also determined by using 20 tablets. The in vitro dissolution studies of the developed SR tablets and immediate release (IR) tablets were carried out using USP type II apparatus (Electrolab, Mumbai, India) at 50 rpm. The dissolution medium consisted of 900 ml of pH 6.8 phosphate buffer solution, maintained at 37 ± 0.5°C. The drug release at different time intervals was measured. The release studies were conducted in triplicate for each batch. These release studies were compared with IR tablets too.
Kinetics and mechanism of drug release
The in vitro release profiles were fitted to Peppas, Hixon-Crowell, Higuchi and zero-order equations (Eqs. ())(1)-(4), respectively) by using the least square method of analysis to understand the mechanism of in vitro drug release and to compare the release profile differences among these matrix formulations.
In Peppas equation, Mt/M 1 (Korsmeyer et al., 1983 ) is the fraction of drug released up to time t, K is the kinetic constant and n is the release exponent indicative of the release mechanism. In Hixon-Crowell (Hixson and Crowell, 1931) , Higuchi (1963) and zero-order (Gibaldi and Feldman, 1967 ) release equations, k 1 , k 2 and k 3 are constants. The Hixon-Crowell equation indicates an erosion dependent release mechanism. On the other hand, the Higuchi equation expresses a diffuse release mechanism. The results were analyzed by one way analysis of variance.
Stability study
Stability studies were carried out as per ICH (Q1A (R2), 2003) guidelines. The optimized matrix tablets were packed in screw capped high density polyethylene containers and isothermally stressed to study the stability under accelerated temperature and relative humidity (RH) conditions (40°C and 75% RH) in stability chambers (Thermo lab, Mumbai, India) for 3 months. Test samples were withdrawn every month and subjected to various tests, including visual inspection for any appreciable change on the tablet surface, assay, hardness, friability and dissolution. F 2 (similarity factor) values were calculated to verify the similarity of the dissolution profiles. FT-IR spectroscopy and differential scanning calorimetry were used to characterize the stability of the formulations.
Bioavailability studies of the optimized formulation in New Zealand white rabbits
The male New Zealand white rabbits were given access to normal standard diet and tap water ad libitum, during the experiment. The animals were housed, two per cage in standard rabbit cages maintained at 22 ± 3°C under a 12 h light and 12 h dark cycle. The animals were acclimatized at least one week prior to the start of the experiment. Rabbits were divided into two groups of six animals each. The weight of the rabbits ranged from 1.5 to 2 kg. The rabbits were fasted for at least 24 h prior to the experiments and were given free access to water. The study was carried out in a cross over design with a wash out period of 7 days between the two dosing. During the first phase, the animals received either the reference product (20 mg of standard QF in distilled water) or the test product (20 mg of QF SR tablets). In the second phase, the rabbits which received the test product were administered with the reference product and vice versa. The reference product was administered by distilled water orally through a catheter. Blood samples (2 ml) were withdrawn from the marginal ear vein at 0, 0.5, 1, 1.5, 2, 4, 6, 8, 10, 12 and 24 h after the oral administration of the test/reference products to each of the rabbits. The blood samples were centrifuged at 3500 rpm for 5 min. The plasma samples (0.5 ml) were stored at À70°C until analyzed by the HPLC. Maximum plasma concentration (C max ) and time to reach the same (T max ) after oral administration were determined from the plasma concentration values. The measured plasma concentrations served to calculate the area under the plasma concentration-time curve from time zero to the last concentration time point (AUC 0-t ) and the area under the plasma concentration-time curve from time zero to infinity (AUC 0-inf ). AUC 0-t was calculated according to the trapezoidal rule. AUC 0-inf was calculated by the sum of AUC 0-t and the last measured concentration divided by the elimination constant (Ct/k eli ). The relative bioavailability of the optimized once daily SR tablets of F-5 was compared with the reference QF in healthy rabbits. The results were analyzed by unpaired Student 't' test. In addition, the 95% confidence level is considered for testing. Each test animal was compared with the reference individually at the respective time point.
Results

Characterization of the polysaccharide
The physicochemical properties of polysaccharide are shown in Table 2 . The angle of repose data reveals that GG has good flow properties. The pH of GG in solution form is close to neutral. This indicates GG may not cause any irritation to the epithelium and mucous membrane in the GI tract. The water absorption and swelling index of GG are high. GG can, therefore, maintain the aqueous equilibrium between the dosage form and the surrounding medium. The Scanning Electron Micrograph (SEM) of GG is shown in Fig. 1 . The micrograph 
Compatibility studies of QF with GG
The IR spectrum shows a sharp peak at 3317 cm À1 for QF indicating the presence of free OH group. The peaks at 1305 and 1130 cm À1 show the presence of aromatic C-N and C-S, respectively. The presence of aliphatic chain and aromatic C-C groups are indicated by the peak at 3074 and 1599 cm À1 , respectively. All these groups are seen in the formulation also. The formulation does not contain any new peaks. The DSC thermograms of the formulation also show the characteristic endothermic peak of the QF at 177°C (Fig. 2) . The studies thus reveal no interactions between the GG and the drug. The polysaccharide, GG, and the drug are thus compatible with each other.
Based on the physicochemical, toxicity and compatibility studies GG was selected as a carrier for developing SR tablets.
Physical evaluation of the granules and tablets
The optimized granules:fines ratio was 60:40. The granule properties of the different QF SR batches are shown in Table 3 . The data reveal that all the batches are having moderate to good Development of sustained release antipsychotic tablets using novel polysaccharide isolated from Delonix regiaflow capacity, LBD and TBD. These properties were assisted to uniform fill weight and avoided some problems during the tablet compression. Each batch shows limited moisture content and good Carr's index. Hence, all the batches were containing uniform drug content and hardness of the tablets. The tablet characteristics of the different batches are shown in Table 4 . It is observed that the friability values decrease as the polysaccharide concentration increases. All the batches are uniform in thickness with respect to hardness. Optimum tablet hardness has been maintained by compression force and thickness, hence, the tablets have enough strength for shipping. All the physical parameters of the tablets are thus found to be practically within controls. The concentration of the polysaccharide does not exhibit any effect on the drug content of different batches.
In vitro dissolution studies and kinetic mechanism
Six different batches F-1 to F-6 were prepared and the in vitro release results are shown in Fig. 3a and b . The data reveal that the concentration of polysaccharide has a significant impact on the drug release. Drug released from all the batches was nearly equivalent up to 1 h except in the case of IR tablets. However the drug release that differs at 2 h (Fig. 4 ) from all the batches is between 21% and 39%. The drug release decreases when the GG concentrations have increased. In the case of IR tablets, they disintegrated rapidly and QF dissolves in the medium very soon. Almost, 95% of QF release has occurred within 1 h. The drug release from the batches with 25% and 30% polysaccharide content was comparatively slower than tablets with 5-20% polysaccharide content (F-1 to F-4). The dissolution for the first 12 h period for the F-5 batch tablets is steady till the polymer relaxation becomes predominant (Fig. 4) .
The release data were fitted to different kinetic models to determine the mechanism of drug release. Zero order, first order, Higuchi, Hixon-Crowell and Korsmeyer-Peppas are the major models to identify the drug release from sustained release formulations. The kinetics of drug release of QF from SR matrices is shown in Table 5 and Figs. 5 and 6. The regression coefficients and release rate constant values were considered for fitting. The data reveal that the drug release from GG matrix tablets follow matrix type except F-4 and F-5 which follow first order and Hix.crow type. The release mechanism of F-5 tablets is primarily by diffusion of the dissolved QF across the gel layer. At the end of 12 h dissolution the tablets formulated with 25% polysaccharide content (F-5) showed a better release profile than the other formulations (Fig. 4) . F-5 was, therefore, selected for evaluation of stability and bioavailability studies.
Stability studies
The results of the stability studies of the selected batch, F-5, are shown in Table 6 . The accelerated stability studies indicate that the developed SR tablets are unaffected after 3 months storage under accelerated conditions as no changes are observed in the differential scanning calorimetric thermograms. Moreover, no signs of visually distinguishable changes are observed in the appearance, texture and color of the formulation. The data on drug content and friability are comparable with those of the control samples and are within the limits. F 2 values of 50-100 indicate similarity between the dissolution profiles. On the basis of these results, it may be concluded that the optimized formulation developed is stable under accelerated conditions for 3 months.
Pharmacokinetic evaluation
The results of the mean pharmacokinetic profiles calculated for the developed SR tablets and the reference QF are presented in Table 7 and Fig. 7 . The results show very rapid drug absorption from the reference as revealed by a T max of 4.83 ± 1.03 h as compared to a T max of 7.33 ± 0.98 QF for SR tablets. The developed SR tablets gave a plasma concentration-time profile typical of the prolonged dissolution characteristic of an SR formulation. The developed F-5 thus demonstrates a longer time to reach the peak concentration than the reference and appear to be more consistent in its overall performance as indicated by a lower variation in plasma concentrations, longer time to peak and lower peak plasma concentration. The data obtained further reveal the absence of a burst-effect in F-5 in fasted, healthy animals. There is significant difference in the extent of absorption as seen from the AUC 0-24 values. However, the AUC 0-inf value for SR tablets is 1.44 times higher than the reference thus, indicating more efficient and sustained drug delivery capable of maintaining plasma drug levels better. This is also evident from Figure 4 Comparitive drug release studies of F-1 to F-6 tablets with immediate release tablets at 2 h and 12 h. the lower elimination rate constant (0.08 ± 0.01) and higher t ½ values (9.02 ± 0.65) for QF SR tablets. The drug release from the GG is thus sustained and could maintain the drug level in blood plasma. The in vivo concentration-time profile thus shows that the tablets maintain their integrity while traversing the stomach. There was a statistically significant (P < 0.0001) difference that occurred at the time of 1 h and continued to be significant up to 24 h when compared to reference.
Discussion
The major difficulties of novel isolated polymers (from the plant parts) are physical appearance and impurities. The physical appearance of seed polysaccharides like tamarind, locust bean and guar are dull brown in color. This is due to their seed cover and other seed parts color that might drain and stain the polysaccharides during the extraction process. But, the cotyledon portion of the GG seeds is very thick and transparent (no stain) even after being boiled. Hence the process of cotyledon portion isolation was easy and gave high quantity of the yield. The transparent white color favors the appearance of the tablet too. The impurities of the polysaccharide might offer brown or black colored spots on the tablet that appear awful. Impurities are also involved in the tablet sustained release properties. They absorb the dissolution medium rapidly and dissolve soon. These dissolved portions act as channels. The surrounding medium could enter into the tablet core via these channels easily, therefore, the tablet gets disintegrate rapidly. Thus, the sustained release could not be achieved. Unlike this, the thick and transparent isolated cotyledon portion of GG seeds could be washed easily hence there was the absence of impurities and color of the GG. The GG did not have any toxicity and is suitable for the pharmaceutical application. It is stable in all the conditions individually as well as with the excipients. The granules' properties show that GG envelops QF uniformly and the blending was done properly, hence, the drug content of each batch is uniform and under the limit. All the granules' parameters are under acceptable limits. The prepared tablets are in uniform thickness and hardness. This is due to physicochemical characters of the GG and the uniform mixing of the tablet blend.
The dissolution method development has done using different pH buffer solutions and different paddle speeds. Finally, pH 6.8 phosphate buffer solution with 50 rpm was selected. The tablet(s) were settled down as soon as they put into the dissolution medium and remained at the bottom of the basket. This shows that the prepared tablets are not having any air entrapment. Further, the tablets did not liberate any air bubble in the dissolution medium during the entire study. GG did not react with the other excipients, hence, it does not liberate the gas. If GG contains any gas, the tablet may float on the dissolution medium. The tablets did not float at the center of the basket during dissolution studies too. This is due to higher surface tension than water and limited density of GG. The dissolution studies show that the drug dissolves nearly up to 1.5 h due to the possibility of the surface of the tablets containing free QF. The soluble nature of QF in dissolution medium is also another causative. Hence, in Fig. 3a and b show a superimposed graph up to 1.5 h. After 1.5 h or from 2 h onward the GG forms a gel layer. At 2 h the QF release from F-1 to F-6 is 39. 01%, 36.22%, 31.41%, 30.77%, 26.89% and 21 .53% respectively (Fig. 4) . At this point, the drug release increases when the polymer concentration decreases. The rough surface with pores and crevices of the GG forms a strong matrix and retains the drug prolongation. Increasing the concentration of the GG decreases the size of the matrix channels that leads to increases in the degree swelling. The nature of starch 1500 in water and the gel forming capacity of GG could be other reasons for the drug release retardant. The strong matrix can form between GG and starch 1500. This hydrogel matrix had low (Fig. 4) . There is not much difference in drug release (%) from all the batches. This is due to prolonged duration of tablets in dissolution medium that may enhance the channel opening wide and increase the solubility of the excipients. When compared to all other batches F-5's release pattern was good and close to expected results. Unlike xanthan gum, GG is not pH dependable. Xanthan gum, an ionic polymer is a naturally available sustained release agent. Its matrix has been slower at lower pH values (Billa and Yuen, 2000) . When the dissolution takes place it swells and the outer layer of the tablets appeared to be hydrated. A progressive boost in the size of these hydrates, is particularly visualized for matrices' steady loss of integrity, resulting from the hydrodynamic stress induced by the dissolution apparatus (Ueberreiter, 1967) . The kinetic data reveal that QF release from GG matrix tablets follow matrix type except F-4 and F-5 which follow first order and Hix.crow type. Mechanism of these matrices swells politely and may hold the drug in the gel layer. It is likely that as the concentration of the drug becomes high within the gel matrix and its thermodynamic activity or chemical potential increases, the gel layer around the tablet core actually acts almost like a rate-controlling membrane resulting in linear drug release. The kinetic release mechanism of F-5 indicates the release might be the dissolution of the QF initially rapid due to free QF at the surface of the tablets and the matrix absorbed water started swelling gradually. As the dissolution progressed, the gradual swelling of the outer layer created proportionally new areas for the QF diffusion. Since the matrix was hydrophilic, the permeation of dissolution medium in the matrix had taken place and it initiated dissolution of the QF from the inner layers. The balance between swelling and gelling characteristics of the matrix system was maintaining the desired QF release rate.
The pharmacokinetic profile for the developed SR tablets has given the expected sustained release result as that of the dissolution studies. SR tablets started sustained release action after ingestion when compared to the IR tablets. The prompt sustained release has occurred up to 3 h. This may not be due to the acidic medium. This is because of the free QF present on tablet surface (like that of the dissolution results). The release from F-5 could be rapid if the GG is pH dependent or acid soluble. Expectedly, the release pattern of SR tablets is sustained. The drug release might be slower after 3 h when compared to the initial. The QF release of SR is slow and steady up to 24 h. The IR tablets may disintegrate rapidly and get absorbed. The high elimination constant has occurred compared to SR tablets. This is suggesting that the gel is strong enough to resist the powerful peristaltic contractions that normally occur in the fasted state which opens the pylorus and clears the stomach of any residual material. The T max of SR tablets is comparatively longer than the IR tablets. This is also an evidence for the prolonged action of developed SR tablets. Hence the GG has SR properties and is not a pH dependent polymer. From the environmental aspect, an agricultural waste, GG seeds are used as a source of valuable materials of commercial pharmaceutical importance.
Conclusion
An isolated polysaccharide from the seeds of D. regia exhibits good physicochemical properties and does not have toxicity. In vitro drug release studies of the developed F-5 batch SR tablets reveal that drug release takes place slowly up to 24 h period and is fitted into the Hixon-Crowell kinetic mechanism. Drug absorption from the developed SR tablets is higher when compared to the reference drug in healthy rabbits thus indicating that they maintain drug-plasma levels. There is no difference in the AUC values between the formulation and the reference drug and no significant difference in their absorption was found thus indicating the complete absorption of QF. The isolated polysaccharide, GG from Gulmohar gum can, therefore, be used as a carrier for developing sustained release formulations (Fig. 7) . Figure 7 Plasma concentration-time profile of quetiapine fumarate (n = 12) from developed F-5 tablets and reference tablets. Statistically significant (P < 0.0001) difference occurred at the time of 1 h and continues to be significant up to 24 h when compared to the reference.
